Connect with us

National

The reasons why regulators aren’t greenlighting existing medical treatments that show promise for coronavirus – ABC News

There are existing medications and treatments that seem to show some promise and have already been evaluated for safety. So why not just greenlight these? What are the potential downsides to this approach?

Published

on

post featured image

Aspirin was originally developed as a painkiller, but now many people take it every day to prevent heart disease.
Scientists are taking a similar approach in their hunt to find medications to treat coronavirus: looking for drugs already approved for use in managing certain conditions that show promise in treating COVID-19.
Using a repurposed drug is the easiest path to take when looking for a new medical treatment, explains infectious diseases expert Sharon Lewin, director of the Peter Doherty…

Click here to view the original article.